Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US.
Elena Losina, Alexander M Weinstein, William M Reichmann...
https://pubmed.ncbi.nlm.nih.gov/23203864/Actively Recruiting
Led by University of Chicago · Updated on 2026-09-04
140
Participants Needed
5
Research Sites
4 weeks
Total Duration
Researchers are evaluating whether the location of a steroid injection affects pain relief in patients with moderate-to-severe medial knee osteoarthritis. The study compares pain experienced by patients who receive corticosteroid injections either on the inside anteromedial or outside anterolateral of the knee. This trial aims to better understand how injection site influences treatment outcomes for knee osteoarthritis. Participants are randomly assigned to receive a corticosteroid injection either on the anteromedial or anterolateral side of the knee. The injections are given as part of standard care, and patients will then be monitored through scheduled follow-ups. The study includes multiple time points for assessment, occurring before the injection and at 2, 6, and 12 weeks afterwards. During the study, participants will complete pain surveys and questionnaires about their knee function and satisfaction with the injection. Pain measurements and knee osteoarthritis outcome scores will be collected at baseline and during phone follow-ups at 2, 6, and 12 weeks post-injection. Researchers will also evaluate patient impressions of change over time. This monitoring helps assess how pain and function evolve following the different injection sites.
CONDITIONS
Patient Pain and Function in Medial Knee Osteoarthritis After Anteromedial vs Anterolateral Intra-Articular Corticosteroid Injection
M
Malik J Scott, B.A.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Chicago
Lead Sponsor
AdventHealth
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Anteromedial Knee Injection | Anterolateral Knee Injection |
|---|---|---|
| What it is | A corticosteroid is injected into the knee joint using the anteromedial approach (front-inside of the knee). This technique is used for pain relief and reducing inflammation in osteoarthritis. | A corticosteroid is injected into the knee joint using the anterolateral approach (front-outside of the knee). This widely used technique also targets pain and inflammation in osteoarthritis. |
| Role in trial | Investigational arm; tests whether the anteromedial approach results in more effective pain relief or function improvement than anterolateral injection. | Active comparator arm; provides the comparison standard for the anteromedial approach. |
| Primary use | Pain relief and improved function for moderate-to-severe medial compartment knee osteoarthritis. | Pain relief and improved function for moderate-to-severe medial compartment knee osteoarthritis. |
| How it is given or performed | The corticosteroid is injected into the knee joint through the anteromedial (front-inside) portal, guided by clinical anatomical landmarks. | The corticosteroid is injected into the knee joint through the anterolateral (front-outside) portal, using clinical anatomical landmarks for needle placement. |
| Evidence status | How the two approaches compare directly is under study in this trial. Meta-analyses find corticosteroid injections generally provide moderate short-term pain relief in knee osteoarthritis. | No published evidence confirms superiority of the anterolateral over anteromedial approach. Both are used in clinical practice, with outcome differences being investigated. |
| Important limitations | Procedure accuracy may vary by operator experience, and current guidelines do not specify an optimal anatomical portal. Broader clinical outcomes and long-term safety are not established by this trial. | Accuracy of the procedure depends on technique and practitioner. There is currently no consensus on which approach delivers better clinical outcomes or injection accuracy. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to enroll in the trial.
1 visit (in-person)
Duration - Single visit with follow-up over 12 weeks
Participants receive a corticosteroid injection either on the anteromedial or anterolateral side of the knee.
Follow-up surveys at 2, 6, and 12 weeks after injection (phone or online)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Elena Losina, Alexander M Weinstein, William M Reichmann...
https://pubmed.ncbi.nlm.nih.gov/23203864/Jörg Lützner, Philip Kasten, Klaus-Peter Günther...
https://pubmed.ncbi.nlm.nih.gov/19491912/Angela V Bedenbaugh, Machaon Bonafede, Elizabeth H Marchlewicz...
https://pubmed.ncbi.nlm.nih.gov/34054301/Ye Huang, Peilai Liu
https://pubmed.ncbi.nlm.nih.gov/41508090/M van Middelkoop, N K Arden, I Atchia...
https://pubmed.ncbi.nlm.nih.gov/26836288/Yuchen He, Zhong Li, Peter G Alexander...
https://pubmed.ncbi.nlm.nih.gov/32751156/Fausto Salaffi, Andrea Stancati, Carlo Alberto Silvestri...
https://pubmed.ncbi.nlm.nih.gov/15207508/Elizabeth A Wright, Jeffrey N Katz, Miriam G Cisternas...
https://pubmed.ncbi.nlm.nih.gov/20706165/Mugdha Gore, Kei-Sing Tai, Alesia Sadosky...
https://pubmed.ncbi.nlm.nih.gov/21682606/Su-Yeon Kye, Keeho Park
https://pubmed.ncbi.nlm.nih.gov/27992846/University of Chicago
Lead Sponsor
AdventHealth
Collaborating Sponsor